Measured HbA1c (a three-month blood-sugar marker) and body-weight change
GHK-CU is a naturally occurring copper-complexed tripeptide (Gly-His-Lys)
This compounded therapy combines both peptides to deliver synergistic healing and recovery effects that neither peptide achieves alone
High-dose therapy may also cause a brief increase in blood pressure, though this usually returns to baseline within a few hours
The combination is most useful for patients with one or more of the following: BMI of 30 or higher , or BMI 27 with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea History of fatigue, low mood, or brain fog on previous diets or weight loss attempts Metformin use for type 2 diabetes or pre-diabetes (chronic metformin reduces B12) Long-term proton pump inhibitor use such as omeprazole, pantoprazole, or lansoprazole Vegetarian or vegan diet with limited animal protein intake Adults over 50 , where B12 absorption naturally declines Active strength training or higher physical demands while on a calorie deficit Patients who dont fit any of these profiles can still take semaglutide alone, then add B12 if symptoms suggest it